Early Administration of Bosentan in High‐Risk COVID‐19 Outpatients at Risk of Sarcopenia: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Authors

Institutions

Publication Details

Journal
Journal of Cachexia Sarcopenia and Muscle
Published
2025-03-04
DOI
https://doi.org/10.1002/jcsm.13753
Citations
3
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
4.17
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early Administration of Bosentan in High‐Risk COVID‐19 Outpatients at Risk of Sarcopenia: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Farid Zayeri, Shaahin Shahbazi, Zahra Vahdat Shariatpanahi, Erfan Shahbazi
3 citations
Journal of Cachexia Sarcopenia and Muscle
Long-Term Effects of COVID-19
4.17
article

Early Administration of Bosentan in High‐Risk COVID‐19 Outpatients at Risk of Sarcopenia: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Farid Zayeri, Shaahin Shahbazi, Zahra Vahdat Shariatpanahi, Erfan Shahbazi
article en
3 citations

Abstract

No abstract available for this paper.
Journal of Cachexia Sarcopenia and MuscleVol. 16(2)
Medical University of Ilam (IR), National Nutrition and Food Technology Research Institute (IR), Ilam University (IR), Shahid Beheshti University of Medical Sciences (IR), Tehran University of Medical Sciences (IR)
Good health and well-being
Openalex Percentile: Top 7%
Long-Term Effects of COVID-19
4.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.